Maxx Orthopedics’s Revision Knee System Receives FDA 510(k) Clearance

Maxx Orthopedics announced that it has received U.S. Food and Drug Administration 510(k) clearance for its Freedom PCK Components, a revision knee replacement system.

Advertisement

The Freedom PCK combines Maxx’s previously FDA-cleared Freedom Stemmed Tibial Components with patent-pending femoral components and constrained liners to create a bone-conserving, low-profile revision knee system.

 

Maxx Orthopedics is a subsidiary of Maxx Medical, which develops and markets orthopedic medical devices on an international scale.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.